Related to PAR-17-205

Title Announcement Number Related Issuing Org Release Date Opening Date Expiration Date Activity Code
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)  PAR-17-205    NINDS  03-09-2017  07-09-2017  12-21-2017  UG3/UH3 
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UH2/UH3)  PAR-14-293  Related Link  NINDS  07-22-2014  09-21-2014  03-09-2017  UH2/UH3 
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)  PAR-17-201  Related Link  NINDS  03-09-2017  07-09-2017  12-21-2017  U44 
NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)  RFA-NS-18-002  Related Link  NINDS  09-20-2017  11-15-2017  12-16-2017  P50 
Notice of National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Drug Abuse (NIDA) Interest in Blueprint Neurotherapeutic Network Applications Directed at Small Molecule Non-Addictive Pain Therapies  NOT-NS-18-027  Related Link  NINDS  12-13-2017       
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional  PAR-18-546  Related Link  NINDS  12-21-2017  01-07-2018  05-08-2020  UG3/UH3 
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)  PAR-18-762  Related Link  NINDS  04-19-2018  05-19-2018  05-08-2021  R61/R33 
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)  PAR-18-761  Related Link  NINDS  04-19-2018  05-19-2018  05-08-2021  R61/R33 


Technical Issues: E-mail OER Webmaster